Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Prior Authorization May Be Rechallenged By PhRMA If Harm Is Shown

Executive Summary

Maine's Rx rebate program can be challenged if the prior authorization aspect is harming patients, a federal appeals court said in overturning an injunction against initiation of the discount plan.
Advertisement

Related Content

PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments
PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments
Tri-State Rx Purchasing Pool Estimates 10% To 15% Savings Over Medicaid
Tri-State Rx Purchasing Pool Estimates 10% To 15% Savings Over Medicaid
Pfizer Florida Formula: Free Goods In Exchange For Formulary Status
Pfizer Florida Formula: Free Goods In Exchange For Formulary Status
Medi-Cal Expansion May Be Next Case For NACDS; Suit Filed Against Florida
Maine Rx Negotiations With Manufacturers Continue After Court Ruling
Maine Rx Negotiations With Manufacturers Continue After Court Ruling
Advertisement
UsernamePublicRestriction

Register

PS037871

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel